spevigo
boehringer ingelheim international gmbh - spesolimab - psoriasis - immunosuppressiva - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.
zynlonta
swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - antineoplastiske midler - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.
tevimbra
novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antineoplastiske midler - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.
onglyza
astrazeneca ab - saxagliptin - diabetes mellitus, type 2 - narkotika anvendt i diabetes - add-on combination therapyonglyza is indicated in adult patients aged 18 years and older with type-2 diabetes mellitus to improve glycaemic control:as monotherapy:in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;as dual oral therapy:in combination with metformin, when metformin alone, with diet and exercise, does not provide adequate glycaemic control;in combination with a sulphonylurea, when the sulphonylurea alone, with diet and exercise, does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate;in combination with a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate;as triple oral therapy:in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control;as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.
cerazette 75 mikrogram filmovertrukne tabletter
n.v. organon - desogestrel - filmovertrukne tabletter - 75 mikrogram
delamonie 75 mikrog filmovertrukne tabletter
sandoz a/s - desogestrel - filmovertrukne tabletter - 75 mikrog
desogestrel "orifarm" 75 mikrogram filmovertrukne tabletter
orifarm generics a/s - desogestrel - filmovertrukne tabletter - 75 mikrogram
desogestrel "sandoz" 75 mikrogram filmovertrukne tabletter
sandoz a/s - desogestrel - filmovertrukne tabletter - 75 mikrogram
desogestrel "stada" 75 mikrogram tabletter
stada arzneimittel ag - desogestrel - tabletter - 75 mikrogram
doxycyclin "orifarm" 100 mg tabletter
orifarm a/s - doxycyclinmonohydrat - tabletter - 100 mg